Skip to main content

Table 2 Comparison of surgical conditions and clinical outcomes between the two groups

From: Outcomes of prophylactic lauromacrogol injection versus non-injection in patients with endogenous cesarean scar pregnancy treated by hysteroscopic surgery: a retrospective cohort study

Parameter

Non-L group (n = 53)

L group (n = 78)

P value

Cure rate (%)

52 (98.1)

77 (98.7)

1

Operating time (min)

29.87 ± 13.51

29.58 ± 19.99

0.926

Intraoperative blood loss (mL)

15.0 (10.0, 20.0)

20.0 (10.0, 30.0)

0.105

Hemoglobin change

12.0 (4.0, 16.0)

10.5 (6.0, 17.0)

0.952

Time to β-hCG normalization (days)

28.07 ± 8.51

29.39 ± 9.92

0.586

Complications (%)

  

 < 0.001*

 Overall

0 (0)

36 (46.2)

 

 Abdominal pain

0 (0)

28 (35.9)

 

 Massive bleeding

0 (0)

5 (6.4)

 

 Bradycardia

0 (0)

3 (3.8)

 

Uterine packing rate (%)

2 (3.8)

7 (9.0)

0.311

Hospital day(day)

4.85 ± 1.12

5.44 ± 1.08

0.003*

Hospital stay cost (¥)

6148.75 ± 1028.71

9016.61 ± 1181.19

 < 0.001*

 Surgery

1266.12 ± 282.97

1296.41 ± 265.14

0.535

 Medical supplies

155.9 (21.0, 819.0)

1348.0 (1062.0, 1548.0)

 < 0.001*

 Medication

508.03 ± 225.35

2033.06 ± 431.73

 < 0.001*

 Ultrasound and imaging

495.36 ± 140.62

709.52 ± 137.57

 < 0.001*

  1. Data are presented as mean ± standard deviation, median (25th, 75th percentile), or n (%). *Statistically significant